The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
Fuzhengtongmai Capsule for Treatment of Acute Cerebral Infarction
Author(s): 
Pages: 863-865
Year: Issue:  10
Journal: Research of Traditional Chinese Medicine

Keyword:  cerebral infarctionacuteFuzhengtongmaicapsulesLuoxintong;
Abstract: Objective To observe the effect of Fuzhengtongmai(FZTMC) Capsules(FZTMC) on acute cerebral infarction(ACI) with Qi deficiency and blood stasis,phlegm stagnation and collaterals bi(TCM).Methods Eighty-one patients with acute cerebral infarction( Qi deficiency and blood stasis,phlegm stagnation and collaterals bi-syndrome diagnosis by TCM) were divided into two groups randomly: Treatment group(TG,n=51) treated by FZTMC and control group (CG,n=30) treated by Luoxintong for 28 days.Results The total effective rate was 94.12% in the treatment group and 93.33% in the control group respectively(P>0.05).The marked effective and cure rate was higher in TG(74.51%) than that in CG(40.00%). The recovery degree of neurological deficit and the improvement of blood rheology were better in TG than that in CG(P<0.05 or P<0.01). No side-effects were found.Conclusion The results show that FZTMC Could promote the functional recovery of damaged cerebral cells and decrease the disability rate.
Related Articles
No related articles found